52 Pfizer cuts earnings, revenue guidance as vaccine sales slump. (www.cnbc.com) posted 1 year ago by BerlinWallCrosser 1 year ago by BerlinWallCrosser +52 / -0 Pfizer slashes full-year earnings and revenue guidance as Covid treatment, vaccine sales slump Pfizer said it anticipates sales of its Covid treatment Paxlovid and its vaccine will be $9 billion less than it had expected. 3 comments share 3 comments share save hide report block hide replies
I was in MBA school and we studied this as a basic maxim. The company often fails if it kills it's customers.